Speakers

Dr. Konnikova’s team focuses on the development of early life immunity particularly at barrier sites such as the gastrointestinal tract and the maternal-fetal interface with a particular focus on T cell biology. 

The Littman lab studies how information from the environment, including microbiota and metabolites, is relayed to cells of the immune system and how this is manifested in homeostatic processes as well as in pathological conditions.

The Mackay Group studies memory T cell responses, with a focus on the signals that control tissue-resident memory T cell differentiation, and a view to harness these cells to develop new treatments against infection, cancer and autoimmune conditions.

The Mehandru lab focuses on multidimensional profiling of the mucosal immune system to understand the pathogenesis of IBD and determine what distinguishes individuals who respond to therapy from those who do not. They apply bioinformatics to analyze complex, high-dimensional data.

The Pulendran lab focuses on understanding the mechanisms by which the innate immune system regulates adaptive immunity and harnessing such mechanisms in the design of novel vaccines.

The Rieder group focusses on the discovery of novel mechanisms of intestinal fibrogenesis, the prediction of fibrostenosing disease courses and innovative ways to treat IBD patients with established strictures.